Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	91,156	99,488	93,978	98,960	85,331	96,124
Market Cap Growth	5.86%	5.86%	-5.03%	15.97%	-11.23%	-0.78%
Enterprise Value	108,984	119,281	125,376	134,397	126,409	124,464
Last Close Price	2068.00	2257.00	2088.74	2156.46	1794.93	1948.69
PE Ratio	9.17	10.01	12.16	15.97	21.54	30.82
Forward PE	9.21	10.13	11.34	12.53	20.60	28.59
PS Ratio	1.04	1.14	1.24	1.45	1.43	1.73
PB Ratio	1.02	1.11	1.18	1.51	1.55	1.71
P/TBV Ratio	1.85	2.02	2.58	4.21	6.23	6.90
P/FCF Ratio	7.93	8.66	10.12	9.20	10.82	15.60
P/OCF Ratio	7.05	7.70	7.71	7.52	9.53	13.94
EV/Sales Ratio	1.25	1.37	1.66	1.97	2.12	2.25
EV/EBITDA Ratio	5.60	6.04	7.30	8.86	10.74	15.80
EV/EBIT Ratio	9.14	9.78	13.03	14.91	19.86	36.15
EV/FCF Ratio	9.48	10.38	13.51	12.49	16.03	20.20
Debt / Equity Ratio	0.46	0.46	0.58	0.75	0.95	0.89
Debt / EBITDA Ratio	2.08	2.08	2.69	3.26	4.44	6.34
Debt / FCF Ratio	3.58	3.58	4.98	4.60	6.62	8.11
Asset Turnover	0.56	0.56	0.53	0.53	0.48	0.49
Inventory Turnover	1.51	1.51	1.48	1.53	1.51	1.53
Quick Ratio	0.92	0.92	0.76	0.71	0.63	0.43
Current Ratio	1.28	1.28	1.06	1.02	0.94	0.69
Return on Equity (ROE)	11.75%	11.75%	10.58%	10.28%	7.14%	5.75%
Return on Assets (ROA)	4.92%	4.92%	4.21%	4.35%	3.23%	1.90%
Return on Capital (ROIC)	5.93%	5.93%	4.99%	5.07%	3.73%	2.22%
Return on Capital Employed (ROCE)	11.60%	11.60%	10.00%	10.30%	7.90%	5.10%
Earnings Yield	10.90%	9.99%	8.23%	6.26%	4.64%	3.25%
FCF Yield	12.61%	11.55%	9.88%	10.87%	9.24%	6.41%
Dividend Yield	2.32%	2.08%	2.11%	1.85%	1.95%	1.75%
Payout Ratio	19.89%	19.89%	25.03%	25.67%	38.83%	50.27%
Buyback Yield / Dilution	0.00%	0.00%	0.21%	2.14%	2.02%	1.38%
Total Shareholder Return	2.32%	2.08%	2.32%	3.99%	3.98%	3.12%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.